182 related articles for article (PubMed ID: 38239204)
1. Nanotechnological synergy of mangiferin and curcumin in modulating PI3K/Akt/mTOR pathway: a novel front in ovarian cancer precision therapeutics.
Alharbi HM; Alqahtani T; Alamri AH; Kumarasamy V; Subramaniyan V; Babu KS
Front Pharmacol; 2023; 14():1276209. PubMed ID: 38239204
[No Abstract] [Full Text] [Related]
2. Enhancing plant-derived smart nano inhibitor in targeting mammalian target of rapamycin (mTOR) in breast cancer using Curcuma longa-derived compound curcumin.
Alamri AH; Debnath S; Alqahtani T; Alqahtani A; Alshehri SA; Ghosh A
Environ Sci Pollut Res Int; 2023 Jan; ():. PubMed ID: 36719580
[TBL] [Abstract][Full Text] [Related]
3. Curcumin and Plumbagin Synergistically Target the PI3K/Akt/mTOR Pathway: A Prospective Role in Cancer Treatment.
Ahmad I; Hoque M; Alam SSM; Zughaibi TA; Tabrez S
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047624
[TBL] [Abstract][Full Text] [Related]
4. Mangiferin inhibits cell migration and angiogenesis via PI3K/AKT/mTOR signaling in high glucose‑ and hypoxia‑induced RRCECs.
Shi J; Lv H; Tang C; Li Y; Huang J; Zhang H
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33899114
[TBL] [Abstract][Full Text] [Related]
5. A novel front in sustainable microbial management: computational analysis of curcumin and mangiferin's synergistic action against
Perveen K; Bukhari NA; Alshaikh NA; Kondaveeti SB; Alsulami JA; Debnath S; Kumarasamy V
Front Microbiol; 2024; 15():1304234. PubMed ID: 38646635
[TBL] [Abstract][Full Text] [Related]
6. Curcumin and resveratrol inhibit chemoresistance in cisplatin-resistant epithelial ovarian cancer cells via targeting P13K pathway.
Muhanmode Y; Wen MK; Maitinuri A; Shen G
Hum Exp Toxicol; 2022; 41():9603271221095929. PubMed ID: 35722665
[TBL] [Abstract][Full Text] [Related]
7. Curcumin and resveratrol inhibit chemoresistance in cisplatin-resistant epithelial ovarian cancer cells via targeting P13K pathway.
Muhanmode Y; Wen MK; Maitinuri A; Shen G
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S861-S868. PubMed ID: 34791915
[TBL] [Abstract][Full Text] [Related]
8. Curcumin's Dose-Dependent Attenuation of Gastric Cancer Cell Progression Via the PI3K Pathway Blockade.
Xi G; Dong Q; Yang B; Jiao D; Khan S
Dose Response; 2023; 21(4):15593258231203585. PubMed ID: 37933268
[No Abstract] [Full Text] [Related]
9. Nanotechnology-Based Drug Delivery Approaches of Mangiferin: Promises, Reality and Challenges in Cancer Chemotherapy.
Sarfraz M; Khan A; Batiha GE; Akhtar MF; Saleem A; Ajiboye BO; Kamal M; Ali A; Alotaibi NM; Aaghaz S; Siddique MI; Imran M
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627222
[TBL] [Abstract][Full Text] [Related]
10.
Feng L; Lu WH; Li QY; Zhang HY; Xu LR; Zang WQ; Guo WT; Li YF; Zheng WJ; Geng YX; Li Q; Liu YH
Am J Chin Med; 2023; 51(5):1189-1209. PubMed ID: 37314412
[TBL] [Abstract][Full Text] [Related]
11. The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway.
Hamzehzadeh L; Atkin SL; Majeed M; Butler AE; Sahebkar A
J Cell Physiol; 2018 Oct; 233(10):6530-6537. PubMed ID: 29693253
[TBL] [Abstract][Full Text] [Related]
12. Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments.
Maiti P; Plemmons A; Dunbar GL
PLoS One; 2019; 14(12):e0225660. PubMed ID: 31841506
[TBL] [Abstract][Full Text] [Related]
13. Mangiferin ameliorates placental oxidative stress and activates PI3K/Akt/mTOR pathway in mouse model of preeclampsia.
Huang J; Zheng L; Wang F; Su Y; Kong H; Xin H
Arch Pharm Res; 2020 Feb; 43(2):233-241. PubMed ID: 31989480
[TBL] [Abstract][Full Text] [Related]
14. Curcumin downregulates the PI3K-AKT-mTOR pathway and inhibits growth and progression in head and neck cancer cells.
Borges GA; Elias ST; Amorim B; de Lima CL; Coletta RD; Castilho RM; Squarize CH; Guerra ENS
Phytother Res; 2020 Dec; 34(12):3311-3324. PubMed ID: 32628350
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
Liu F; Gao S; Yang Y; Zhao X; Fan Y; Ma W; Yang D; Yang A; Yu Y
Oncol Rep; 2018 Mar; 39(3):1523-1531. PubMed ID: 29328421
[TBL] [Abstract][Full Text] [Related]
16. Curcumin suppresses the progression of laryngeal squamous cell carcinoma through the upregulation of miR-145 and inhibition of the PI3K/Akt/mTOR pathway.
Zhu X; Zhu R
Onco Targets Ther; 2018; 11():3521-3531. PubMed ID: 29950857
[TBL] [Abstract][Full Text] [Related]
17. PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer.
Li H; Zeng J; Shen K
Arch Gynecol Obstet; 2014 Dec; 290(6):1067-78. PubMed ID: 25086744
[TBL] [Abstract][Full Text] [Related]
18. Recent nanotechnological interventions targeting PI3K/Akt/mTOR pathway: A focus on breast cancer.
Sharma V; Sharma AK; Punj V; Priya P
Semin Cancer Biol; 2019 Dec; 59():133-146. PubMed ID: 31408722
[TBL] [Abstract][Full Text] [Related]
19. Label-free-based quantitative proteomic analysis of the inhibition of cisplatin-resistant ovarian cancer cell proliferation by cucurbitacin B.
Yin S; Mai Z; Liu C; Xu L; Xia C
Phytomedicine; 2023 Mar; 111():154669. PubMed ID: 36681055
[TBL] [Abstract][Full Text] [Related]
20. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway.
Wang N; Feng T; Liu X; Liu Q
Acta Pharm; 2020 Sep; 70(3):399-409. PubMed ID: 32074070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
